Correction to: Blood Cancer Journal (2017) 7, e522; doi:10.1038/bcj.2017.2; published online 3 February 2017
Following the online publication of this article, the authors noted that the following funding information needed to be included: This work was supported through the NIH/NCI Cancer Center Support Grant P30 CA008748.
Also, Table 3 requires correction of few numbers. The correction has already been made to the html version of the article.
Additional information
The online version of the original article can be found at 10.1038/bcj.2017.2
Rights and permissions
About this article
Cite this article
Hoseini, S., Cheung, N. Erratum: Acute myeloid leukemia targets for bispecific antibodies. Blood Cancer Journal 7, e552 (2017). https://doi.org/10.1038/bcj.2017.35
Published:
Issue Date:
DOI: https://doi.org/10.1038/bcj.2017.35
This article is cited by
-
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Journal of Hematology & Oncology (2020)
-
Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
Current Oncology Reports (2019)